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Abstract 
The interaction between two mucin types (mucin from porcine stomach – PGM and mucin from 
bovine submaxillary glands – BSM) and gold nanoparticles (GNPs) of various size (5, 20 and 40 
nm) and functionalization (with cysteamine or thioglycolic acid) was studied under physiological 
conditions, in order to investigate the affinity of the nanoparticles to the proteins. 
Different methods are employed to monitor the interactions: UV-Visible and fluorescence 
spectroscopy, fluorescence lifetime, circular dichroism and transmission electron microscopy. 
These studies have shown the formation of a complex between GNPs and both PGM and BSM.  
This aspect could be of great importance for the use of gold nanoparticles for biomedical purposes 
in those diseases where qualitative and quantitative mucin anomalies play an essential role in mucus 
composition and rheology. 
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1. Introduction 
Gold nanoparticles (GNPs) are inert and non-toxic colloidal systems. They are easy to synthesize 
and have a large surface area (Azam, et al., 2009) which can be exploited to easily functionalize the 
particles with molecules or biomarkers through thiol linkage (Ghosh et al., 2008). GNPs can be 
synthesized in different morphologies and size, ranging from 1 to 80 nm, therefore possessing 
unique physical chemical properties including tunable near-infrared (NIR) localized surface 
plasmon resonance (SPR) and the ability to bind amine and thiol groups (Jain et al., 2012). Gold 
nanoparticles have been employed for several decades in many fields (Rashid et al., 2014): imaging 
(Giordano et al., 2016), bioengineering, biotechnology (Khan et al., 2013) and molecular biology 
(Jain et al., 2012) whose applications are dependent on the catalytic, electronic, magnetic and 
optical properties of the particles (Khan et al., 2013). The main application could be their use in 
cancer diagnosis and therapies (Mesbahi and Carlo, 2010). In fact, it was demonstrated that GNPs 
contribute to enhance the generation of reactive oxygen species (ROS) such as ꞏOH, O2- and 1O2, 
under irradiation of X-rays in the diagnostic range (Ferrero et al., 2017; Strigari et al., 2017). 
Recently, some authors have described the preparation of gold nanoparticle (GNPs)-based vaccine 
candidates against the tumor-associated form of the mucin-1 (MUC1) glycoprotein (Cai et al., 
2016). Moreover, very recently a group designed fluorescently encoded poly(vinyl alcohol) (PVA)-
coated gold nanoparticles, functionalized with either negative (−COO−) or positive (−NH3+) surface 
charges, functionalized with a DC-SIGN antibody on the particle surface, enabling binding to a 
dendritic cell surface receptor. In this paper a 3D coculture model consisting of epithelial and  
immune cells (macrophages and dendritic cells) mimicking the human lung epithelial tissue was 
employed to assess the effects of aerosolized GNPs (Fytianos et al., 2017).  
Among issues modulating drug absorption, mucus penetration cannot be ignored. In fact mucus is 
the first barrier that drugs must overcome to be absorbed and gain access to the circulatory system 
(Sigurdsson et al., 2013). The major constituents of mucus are water (95-99.5%) and high molecular 
weight glycoproteins called mucins. In the mucus, these large oligomeric glycoproteins form 
networks which are a chemical and physical barrier that not only protects the epithelial but also 
limits the use of oral administered and inhalatory drugs. 
The proof of concept of using mucin to mimic mucus is widely reported in the literature also by 
Hanes’s group, who state that reduced mucin-binding in vitro has been shown to correlate with 
rapid penetration of nanoparticles through mucus (Xu et al., 2015). Mucin is a large transmembrane 
O-glycosylated protein composed for 75% of carbohydrate and 25% of amino acid (Kesari et al., 
2015). Mucins are the most abundant macromolecules in mucus, about 20 types have been 
identified, and are responsible for the biochemical and biophysical properties of mucus (Kesari et 
al., 2015). An abnormal viscosity and excessive amount of mucus is involved in many respiratory 
diseases such as cystic fibrosis, asthma and pulmonary diseases (Pontremoli et al., 2015).  
In the human body, GNPs have a good distribution and can easily get to the target cells, where they 
can carry out their action. Once GNPs enter the body, they are exposed to various molecules and 
can contact and adsorb many proteins such as ubiquitin, serum albumin, tumor necrosis factor 
(TNF), fibrinogen (Canoa et al., 2015) and cytochrome C. Many studies have investigated these 
interactions that can induce structural and physiological changes on the biomolecules 
(Dobrovolskaia et al., 2009); in particular, ubiquitous proteins are able to interact with GNPs and 
form a protein corona that influences the distribution of nanoparticles in the human body (Wang et 
al., 2015) 
In our previous paper we studied the interaction between CNTs and mucin from porcine stomach 
Type III (PGM) and it was demonstrated that the superficial functionalization of the material has a 
great influence on the binding (Barbero et al., 2016). Following these reasons, we studied the 
interaction between gold nanoparticles and mucin from two commercial mucins, porcine stomach 
Type III (PGM) and mucin from bovine submaxillary glands (BSM), in order to define their affinity 
with GNPs. We analysed the interaction with GNPs of different size (5 nm, 20 nm and 40 nm) and 
positively and negatively charged GNPs, under physiological conditions. The complex GNPs-
mucin was characterized by UV-vis and fluorescence spectroscopy, circular dichroism, and 
transmission electron microscopy (TEM). 
 
2. Materials and methods 
2.1. Reagents 
HAuCl4 was purchased from Sigma Aldrich with a purity ≥ 99.9%, the reducing agents trisodium 
citrate and NaBH4 produced by Sigma Aldrich had a purity ≥ 99% and ≥ 98% respectively. 
Cysteamine and thioglycolic acid were purchased from Sigma Aldrich with a purity ≥ 98% and 
were used to functionalize gold nanoparticles. The solutions employed for the synthesis were 
prepared by dissolving the reagents in Millipore water. 
Mucin from porcine stomach (PGM) (Type III, bound sialic acid 0.5-1.5%, partially purified 
powder) was purchased from Sigma Aldrich. PGM stock solution (1 mg/mL) was prepared by 
dissolving the protein in PBS (phosphate buffer solution, 2 mM, pH=7.4). 
Mucin from bovine submaxillary glands (BSM, Type I-S) was purchased from Sigma Aldrich. 
BSM stock solution (1 mg/mL) was prepared by dissolving the protein in PBS (phosphate buffer 
solution, 2 mM, pH=7.4). 
 
2.2. Synthesis and functionalization of GNPs 
Gold colloidal nanoparticles, with three different sizes 5, 20, 40 nm, were synthesized with the 
Turkevich’s method by varying the ratio between trisodium citrate in order to obtain various 
diameters (Daniel and Astruc, 2004). 
To synthesize GNPs with a size of about 5 nm, 10 mL Millipore water solution of the gold salt (0.5 
mM) were added to 10 mL Millipore water solution of trisodium citrate (0.6 mM); then 0.6 mL of a 
water solution of NaBH4  (0.1 M) was added to the solution. 
15.4 mL NaOH 20 mM and 19.6 mL Millipore water were added to 5 mL of a 25mM HAuCl4 
solution in Millipore water. The solution was heated for 30 minutes at 110°C. 1.2 mL Millipore 
solution of trisodium citrate 170 mM are then added and the sample was again left for 15 minutes at 
110°C. GNPs with a diameter of 20 nm were obtained. 
To obtain GNPs with 40 nm of diameter, the citrate to gold salt mole ratio was 1.36 and 1.5 mL of 
1% trisodium citrate was added to 250 mL HAuCl4 0,25 mM in Millipore water solution. 
Gold nanoparticles with a diameter of 20 nm were functionalized with cysteamine (Cys) and 
thioglycolic acid (Tga) to shape GNPs with a positive and a negative charge, respectively. To 10 
mL GNPs 1mM were added 500 µL Millipore water solution of cysteamine 0.26 mM. To 10 mL 
GNPs 1 mM were added 15 µL Millipore water solution of thioglycolic acid 0.26 mM. 
The GNPs dimension was checked by UV-vis spectroscopy and TEM (see figure S1 SI). 
2.3 GNP-protein complex formation and purification 
1.5-4.5 ml of GNPs (1 mM) were added to a 0.5 mL solution of mucin protein (1mg/mL) in 2 mM 
sodium phosphate buffer, pH 7.2 and the mixture was stirred for 1 h at room temperature. The 
reaction mixture was then loaded on a Sephadex G-25 gel-permeation column. The protein 
complexes were eluted with a sodium phosphate buffer and the elution was monitored by UV/Vis 
spectroscopy.  
 2.3. Instrumentation 
2.3.1. UV-Visible and fluorescence spectroscopy 
UV-Visible measurements were recorded using a UH5300 Hitachi spectrophotometer. Increasing 
concentrations of GNPS (ranging 10 µM - 200 µM, 10 µM - 400 µM and 10 µM - 450 µM for 
GNPs, GNPs-Cys and GNPs-Tga respectively) were added to a constant concentration of PGM 
(0.05 mg/mL) or BSM (0.15 mg/mL). 
Fluorescence spectra were recorded with a Horiba Jobin Yvon Fluorolog2. Emission spectra were 
recorded in the range of 280-500 nm after excitation at 258 nm. The excitation and emission slits 
were 6 nm and 10 nm respectively. A constant concentration of mucin (0.1 mg/mL both for PGM 
and BSM) was analyzed by successive increasing additions of GNPs (ranging 10 µM - 350 µM, 10 
µM - 300 µM and 10 µM - 350 µM for GNPs, GNPs-Cys and GNPs-Tga respectively). 
Fluorescence lifetimes were obtained using a NanoLED source (297 nm) and a photon counting 
detector (TBX04). The goodness of the fit was assessed by the chi-squared value of less than 1.2 
and a residual trace that was symmetric about the zero axes. The final result is an average of three 
independent measurements. 
 
2.3.2.Circular Dichroism 
UV-Circular Dichroism (CD) spectroscopy was used to evaluate changes in the secondary structure 
of PGM and BSM mucin after irreversible adsorption on bare and functionalized GNPs. Watery 
protein solutions (1 mg/mL) and suspensions of purified mucin-GNPs complexes were scanned in 
the far-UV spectral range (four accumulations) over the wavelength region 180-260 nm with a 
scanning speed of 50 nm min-1 using a Jasco J-815 spectropolarimeter equipped with a Xe arc lamp. 
Spectra were recorded in a quartz cuvette (optical path length 0.1 cm). Baseline was subtracted for 
each measurement. Spectra of adsorbed mucin were normalized with respect the one of native 
protein according to the absorbance in the wavelength region where electronic transitions occur. 
After normalization, spectra were compared at the same nominal concentration (1 mg/mL). 
Secondary structure was estimated from the ellipticity [,mdeg] with the CDNN CD spectra 
deconvolution software [Version 2.1, Copyright (C) 1997 Gerald Böhm] and for each sample, a 
maximum standard deviation of 5% in the 185-260 nm spectral range was considered. The declared 
root mean square errors (r.m.s. x 100) in the wavelength range considered for this work (180-260 
nm) is 2.0987 and the average error (%) of predicted secondary structures of the network is 3.98. 
 
2.3.3. Transmission electron microscopy 
High-resolution transmission electron micrographs were obtained with a JEOL 3010-UHR 
instrument operating at 300 kV, equipped with a 2k × 2k pixels Gatan US1000 CCD digital camera. 
Samples of purified mucin-GNPs complex were dried on a carbon-coated copper grid. The nominal 
magnification used to record the complex mucin-GNPS were x500000 and x800000. 
 
3. Results and discussion 
3.1. UV-Visible spectroscopy 
UV-Visible measurements were performed in order to investigate the interaction between GNPs and 
mucin. The spectra were obtained keeping constant the concentration of PGM (0.05 mg/mL) in 
presence or absence of GNPs with a diameter of 5 nm, 20 nm and 40 nm. Spectra of samples with 
an increasing concentration of GNPs showed an increased adsorption intensity compared to mucin 
alone (black line for both PGM and BSM), whose peak is at 258 nm (see SI for spectra). This 
behaviour confirmed the formation of a complex between the nanostructures and the protein. 
The same method was employed to analyse the formation of a complex between PGM or BSM and 
GNPs-cysteamine or GNPs-thioglycolic acid. In both cases, the intensity absorption of the protein 
alone, at around 260 nm, increased with an increasing concentration of GNPs-cysteamine or GNPs-
thioglycolic acid. Moreover, in the case of thioglycolic acid there was also a slight ipsochromic 
shift, further confirming the formation of a complex. 
 
3.2. Fluorescence spectroscopy 
Both PGM and BSM mucins showed an intensive fluorescence at about 360 nm, upon excitation at 
258 nm. Fluorescence spectra are reported in Fig 1a and show a gradually decrease of the PGM 
emission intensity and a slight bathochromic shift, caused by successive additions of increased 
concentrations of GNPs with a diameter of 20 nm (see SI for fluorescence spectra of further 
analyses with GNPs of 5 nm and 40 nm and functionalized GNPs with cysteamine and thioglycolic 
acid). 
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Figure 1 : A) quenching fluorescence of PGM (0.1 mg/mL) in presence of increasing 
concentrations of GNPs of 20 nm (10, 15, 20, 30, 35, 40, 50, 60, 70, 80, 90, 100, 110,  120, 130, 
140, 150  µM); B) quenching fluorescence of BSM (0.1 mg/mL) in presence of increasing 
concentrations of GNPs of 20 nm (10, 30, 60, 90, 100, 120, 150, 170, 200, 250, 270, 300, 350  µM).  
 
A decrease in the fluorescence signal was also obtained for BSM protein (Fig. 1b) after the addition 
of increasing concentrations of GNPs with a diameter of 20 nm (see SI for fluorescence spectra of 
further analyses with GNPs of 5 nm and 40 nm and functionalized GNPs with cysteamine and 
thioglycolic acid). 
The quenching of the emission intensity of mucin was caused by the interaction between the protein 
and the nanoparticles confirming the UV-Vis data. Once the complex formation was assessed, 
binding studies were performed and the obtained steady-state maximum fluorescence intensity was 
recorded. 
 
3.2.1. Data analysis 
The obtained spectroscopic data were analysed by different methods allowing to obtain the 
association and dissociation constants of the interactions, Ka and Kd respectively. The fluorescence 
quenching of mucin was analysed by Stern-Volmer equation (Pontremoli et al., 2017), Eq. 1: 
                                   𝐹଴𝐹 ൌ 1 ൅ 𝐾𝑠𝑣 ሾ𝑄ሿ                                  𝐸𝑞. 1 
where F0 is the fluorescence intensity of mucin alone and F is the fluorescence of mucin together 
with an increased concentration of quencher [Q], i.e. the gold nanoparticles. Ksv describes the 
collisional quenching of fluorescence. Quenching data are presented as plot of F0/F versus [Q], 
yielding an intercept of one on the Y-axis and a slope equal to Ksv. Fluorescence data were also 
analysed by Lineweaver-Burk equation (Pontremoli et al., 2017), Eq. 2: 
                              1𝐹଴ െ 𝐹 ൌ
1
𝐹଴ ൅
𝐾ௗ
𝐹଴ሾ𝑄ሿ                               𝐸𝑞. 2 
where F0 is the steady-state fluorescence intensity of mucin alone and F is the steady-state 
fluorescence intensity of mucin in the presence of increased concentration of quencher, [Q] is the 
gold nanoparticles concentration and Kd is the equilibrium dissociation constant. In the graphs, 
reciprocals of F0-F are plotted versus reciprocals of [Q]. The slope of the line is Kd/F0 ratio while 
the intercept is the reverse of F0. The association constant Ka is calculated from Kd. The last 
equation used to analyse the experimental data is non linear least-squares fit procedures (Pontremoli 
et al., 2017), Eq. 3: 
                                  𝑦 ൌ 𝐵௠௔௫ ሾ𝑄ሿ𝐾ௗ ൅ ሾ𝑄ሿ                                      𝐸𝑞. 3 
in which y is the binding derived by measuring fluorescence intensity, [Q] is gold nanoparticles 
concentration, Bmax is the maximum quantity of GNPS-mucin complex formed at saturation and Kd 
is the equilibrium dissociation constant. The percentage of bound protein is plotted against [Q], 
GNPS concentration. The association constant Ka is calculated from Kd. As an example, Fig. 2 
represents the data analysis of a sample with GNPs and mucin from porcine stomach, Type III (the 
data analysis of all the other samples are reported in the SI). 
The corresponding values of the Stern-Volmer constants (M-1) obtained from the data analysis and 
the values of association (Ka) and dissociation (Kd) constants are reported in Table 1 and 2. 
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Figure 2: data analysis of sample PGM-GNPs (40 nm) by Stern-Volmer equation (a), by non linear 
fit (b), by Lineweaver-Burk equation (c). 
 
Table 1: values of quenching costants and equilibrium association and dissociation constants of 
PGM and GNPs: GNPs of 5 nm, GNPs of 20 nm, GNPs of 40 nm, GNPs-Cys and GNPs-Tga. 
PGM    GNPs 
5nm 
GNPs  
20 nm 
GNPs  
40 nm 
GNPs‐Cys  GNPs‐Tga 
             
 
Stern‐Volmer equation 
 
Ksv (M‐1) 
 
6.48 x 104 
 
 
 
4.34 x 104 
 
2.80 x 104 
 
6.74 x 103 
 
8.57 x 103 
 
 
Non linear fit equation 
 
Kd (M) 
Ka (M‐1) 
 
5.12 x10‐5 
1.95 x104 
 
3.83 x10‐5 
2.60 x10 4 
 
 
3.95 x10‐5 
2.79 x104 
 
1.33 x10‐4 
7.52 x103 
 
1.19 x10‐4 
8.40 x103 
Lineweaver‐Burk 
equation 
 
Kd (M) 
Ka (M‐1) 
 
4.92 x10‐5 
2.03 x104 
 
3.71 x10‐5 
2.69 x104 
 
3.54 x10‐5 
2.81 x104 
 
1.24 x10‐4 
8.00 x103 
 
9.50 x10‐5 
1.08 x104 
 
Table 2: values of quenching costants and equilibrium association and dissociation constants of 
BSM with GNPs of 20 nm, GNPs-Cys, GNPs-Tga.  
BSM    GNPs 20 nm   GNPs‐Cys   GNPs‐Tga  
 
Stern‐Volmer equation 
 
Ksv (M‐1) 
 
5.00 x 104 
 
 
1.88 x 103 
 
 
3.04 x 104 
 
 
Non linear fit equation 
 
Kd (M) 
Ka (M‐1) 
 
6.70 x10‐5 
1.49 x104 
 
 
6.27 x10‐5 
1.59 x104 
 
 
4.48 x10‐5 
2.23 x104 
 
 
Lineweaver‐Burk equation 
 
Kd (M) 
Ka (M‐1) 
 
5.02 x10‐5 
1.99 x104 
 
5.42 x10‐5 
1.84 x104 
 
4.17 x10‐5 
2.11 x104 
 
Ka and Kd are used to find out the affinity between gold nanoparticles and the two mucin types. 
Similar equilibrium values have been obtained employing different data processing methods: Stern-
Volmer equation, non linear fit equation and Lineweaver-Burk equation. 
The analysis of equilibrium dissociation constants between GNPs of various size (5, 20, 40 nm) and 
PG mucin showed values with the same order of magnitude. This means that the size of the gold 
nanoparticle does not influence the interaction with the protein significantly. Instead the binding 
constants change if the interaction between functionalized GNPs and PG mucin occurs. As regards 
the nanoparticles positively charged with cysteamine and PGM, Kd is greater compared to the non-
functionalized ones and so the affinity is lower. The negatively charged GNPs with thioglycolic 
acid show a dissociation value with the PGM similar to GNPs-Cys, the affinity with the protein is 
slightly higher than the positive ones. The analysis of dissociation values between GNPs and BS 
Mucin revealed similar constants for both non- functionalized nanoparticles of 20 nm that for those 
functionalized ones. Moreover, Kd has the same order of magnitude compared to the values found 
by the interaction GNPs-PGM. In conclusion, regarding the analysis with BS mucin, the 
functionalization of the nanoparticles and the charge does not affect significantly on the interaction 
with the protein. 
 
3.2.2. Lifetime 
The fluorescence lifetimes of mucins in the presence of nanoparticles were measured using the 
tryptophan aminoacid residues in the protein structure which have an emission maximum of 360 
nm. Lifetimes were analyzed for mucin (PGM or BSM) alone and then for samples consisted of the 
same concentration of mucin and the concentration of gold nanoparticles at saturation. The 
fluorescence decays of both mucins were fitted by a three exponential equation; with τ1 = 1.3 ns,  
τ2= 3.3 ns and τ3= 7.0 ns for PGM. The first component is responsible for around 64% of the total 
intensity decay (for BSM values see SI). When mucins are excited in the presence of GNPs, τ1 is 
always reduced reaching for example a value of 0.5 ns in the case of PGM interacting with GNP- 
cysteamine. The same behaviour is observed for all the studied interactions; for a complete analysis 
see table S1 in the SI. Lifetime measurements are the most definitive method to distinguish static 
and dynamic quenching. Analyzing the lifetimes in the absence and in the presence of gold 
nanoparticles, some changes in the decay times can be appreciated for both PG and BS mucin 
confirming a collisional quenching. This quenching behavior is also evident in UV-vis spectroscopy 
where no changes (shift and shape) are observed (see SI).  This could be explained by the fact that 
collisional quenching only affects the excited states of the fluorophores (Lakowicz, 2006). 
 
3.3. Transmission Electron Microscopy 
In order to obtain direct evidence on protein corona formation on the GNPs surface, morphological analysis was 
performed using TEM. Fig. 3 reports the images obtained from TEM analysis revealing a thin shell of 
mucin formed over the GNPs.  
    
Figure 3: images of complex GNPs-PGM seen under the transmission electron microscope with a 
magnification of x500000 and x800000. 
 
3.4. Circular Dichroism 
Spectra of PG and BS mucin, both in native and adsorbed forms, were acquired and reported in 
Figure 4. Despite some differences due to the different MW of the two proteins, they both present 
the typical CD spectrum of proteins mainly composed by unordered secondary structures, 
characterized by a negative band at 205-200 nm due to -* electronic transition (Yang et al.,  
2005). If compared with their reference (protein in native form), the spectra of mucin adsorbed on 
bare and functionalized GNPs did not reveal significant changes in the spectra profiles. Slight 
changes can be appreciated in the relative intensities of BSM adsorbed on GNPs if compared to 
BSM in native form (Fig. 4). In order to quantitatively estimate such differences, CD spectra 
deconvolution were performed (the deconvolutions obtained are shown in SI). Despite the change in 
the minima at 207 and 200 nm for PGM and BSM, respectively, they both are composed by similar 
percentage of secondary structural motifs, with a predominance of random coils. Passing to the 
adsorbed proteins, a general increase of β-sheet like motifs is observed, indicative of the formation 
of a layer of proteins in interaction on the surface of GNPs. This is in agreement with the TEM 
observation, where a corona layer can be observed independently by the surface functionalization of 
GNPs. 
 
Figure 4: spectra of both mucins and their complex with GNPs by circular dichroism 
 
4. Conclusions 
In this paper, the interaction between two mucin types (mucin from porcine stomach – PGM and 
mucin from bovine submaxillary glands – BSM) and gold nanoparticles of different size (5, 20 and 
40 nm) and with different functionalization was investigated by using various methods. The 
formation of a complex between both kind of proteins and nanomaterials was assessed by UV-
Visible spectroscopy, where the increase of mucin absorption with the addition of GNPs underlines 
the formation of the complex. This was further proved by fluorescence spectroscopy, in which the 
quenching of mucin intensity is related to the presence of a formed GNPs-protein complex. These 
findings clearly demonstrate that the microenvironment of mucin was changed during the binding 
interaction with all the NPs used. 
Circular dichroism was used to investigate possible changes in the secondary structure of the 
protein after interaction with gold nanoparticles: spectra showed no changes in the structure, despite 
the use of GNPs with different sizes. 
To support and define the formation of a complex, samples were analyzed with TEM and the 
obtained images have shown a mucin layer around the nanoparticles. 
The present results may be of the utmost importance for the use of gold nanoparticles for 
biomedical purposes, in those diseases characterized by the presence of mucus. Next step will be to 
study the behavior of nanoparticles in contact with mucus, whose composition approaches and 
mimics the pathological one. 
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